Russia's Natsimbio to start pneumococcal vaccine production

National Immunobiologicheskaja Company (Natsimbio), one of Russia’s largest vaccines producers that is part of the local state corporation Rostec, has announced plans to launch the production of a vaccine for the prevention of pneumococcal disease during the next several years, The Pharma Letter’s local correspondent reports.

This is the most expensive vaccine, purchased by the Russian Ministry of Health as part of the National immunization Program. For the current year, the maximum initial purchase of the vaccine is set at 3.9 billion roubles (~$62 million).

Overall, according to recent statements by Sergei Kraevoy, Russia’s Deputy Health Minister, total funds allocated for the purchase of vaccines against 12 infections this year is set at 10.6 billion roubles.